- Home
- GLTO vs TANH Comparison
GLTO vs TANH Comparison
Compare GLTO & TANH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLTO
- TANH
- Stock Information
- Founded
- GLTO 2011
- TANH 2001
- Country
- GLTO Denmark
- TANH China
- Employees
- GLTO N/A
- TANH N/A
- Industry
- GLTO Biotechnology: Pharmaceutical Preparations
- TANH
- Sector
- GLTO Health Care
- TANH
- Exchange
- GLTO Nasdaq
- TANH Nasdaq
- Market Cap
- GLTO 4.0M
- TANH 3.5M
- IPO Year
- GLTO 2020
- TANH 2015
- Fundamental
- Price
- GLTO $3.29
- TANH $2.17
- Analyst Decision
- GLTO Buy
- TANH
- Analyst Count
- GLTO 1
- TANH 0
- Target Price
- GLTO $10.00
- TANH N/A
- AVG Volume (30 Days)
- GLTO 86.7K
- TANH 487.6K
- Earning Date
- GLTO 05-08-2025
- TANH 06-17-2025
- Dividend Yield
- GLTO N/A
- TANH N/A
- EPS Growth
- GLTO N/A
- TANH N/A
- EPS
- GLTO N/A
- TANH N/A
- Revenue
- GLTO N/A
- TANH $42,940,136.00
- Revenue This Year
- GLTO N/A
- TANH N/A
- Revenue Next Year
- GLTO N/A
- TANH N/A
- P/E Ratio
- GLTO N/A
- TANH N/A
- Revenue Growth
- GLTO N/A
- TANH N/A
- 52 Week Low
- GLTO $2.01
- TANH $1.45
- 52 Week High
- GLTO $16.07
- TANH $38.40
- Technical
- Relative Strength Index (RSI)
- GLTO 59.33
- TANH 51.42
- Support Level
- GLTO $3.05
- TANH $2.08
- Resistance Level
- GLTO $3.49
- TANH $2.24
- Average True Range (ATR)
- GLTO 0.26
- TANH 0.15
- MACD
- GLTO 0.04
- TANH 0.01
- Stochastic Oscillator
- GLTO 75.76
- TANH 42.98
About GLTO Galecto Inc.
Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of cancer and liver diseases. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.
About TANH Tantech Holdings Ltd.
Tantech Holdings Ltd manufactures bamboo charcoal-based products. The company through its subsidiaries is engaged in the production and distribution of household products along with a trading business which involves the export of charcoal products. It also manufactures electric double-layer capacitors carbon materials and low-emission barbecue charcoal. Its product portfolio includes air purifiers and humidifiers, underfloor humidity control, pillows and mattresses, wardrobe deodorizers, mousepads, and wrist mats, refrigerator deodorant, and charcoal toilet cleaner disks. The company has two reportable segments; the Consumer Product segment, and the Electric Vehicle (EV) segment.